Skip to main content
Caplight Logo









Idevax

Idevax

Private
AntwerpHealthcare & Life Scienceshttps://idevax.com/

Last Round

Series A

Oct 24, 2024

Total Funding Raised

$9.15M

Company Overview

Idevax is a medical device company that develops, produces, and commercializes innovative skin drug delivery devices for prophylactic and therapeutic vaccination and immunotherapy.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

intradermal drug deliverydrug delivery deviceintradermal injectiondrug delivery platformmedtechdose-sparingvaccine deliverystandardized injectionneedle-adapterclinical trial devicetherapeutic deliverybiotech equipmentCE marked deviceISO 13485diagnostic delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Idevax Comparables

Compare Idevax with similar companies based on industry and business-model similarity.

Idevax comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Latch Medical Limited
87%
NanoPass Technologies Ltd.
82%
Satio
77%

Idevax Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 24, 2024
SeedJan 1, 2021

Key People

Founding team and executive leadership

Koen Beyers

CTO, Founder & Director

Founding Team

Vanessa Vankerckhoven

CEO, Co-Founder, Director, Co-Founder, Director

Founding Team

Idevax Investors

Notable investors and investment history

Idevax investors
InvestorRounds
VLAIOSeed
Myosotis InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors grew 228% MoM, reaching 2.8K.

  • Jun 2, 2025

    Monthly visitors grew 96% MoM, reaching 1.5K.

Idevax Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Idevax Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Idevax's valuation, stock price, and market status.

Firmographic Details

HeadquartersAntwerp
Employee Range17
Year Founded2020
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?